[1. Hansen BC. The metabolic X syndrome. Ann NY Acad Sci. 1999; 892:1-24.10.1111/j.1749-6632.1999.tb07782.x]Search in Google Scholar
[2. Skyler J. Diabetes mellitus: pathogenesis and treatment strategies. J Med Chem. 2004; 47:4113-7.10.1021/jm0306273]Open DOISearch in Google Scholar
[3. Noor H, Ashcroft SJ. Antidiabetic effects of Tinospora crispa in rats. J Ethnopharmacol. 1989; 27:149-61.10.1016/0378-8741(89)90087-1]Open DOISearch in Google Scholar
[4. Noor H, Hammonds P, Sutton R, Ashcroft SJ. The hypoglycaemic and insulinotropic activity of Tinospora crispa: studies with human and rat islets and HIT-T15 B cells. Diabetologia. 1989; 32:354-9.10.1007/BF00277258]Open DOISearch in Google Scholar
[5. Noor H, Ashcroft SJ. Pharmacological characterisation of the antihyperglycaemic properties of Tinospora crispa extract. J Ethnopharmacol. 1998; 62:7-13.10.1016/S0378-8741(98)00008-7]Open DOISearch in Google Scholar
[6. Noipha K, Purintrapiban J, Herunsalee A, Ratanachaiyavong S. In vitro glucose uptake activity of Tinospora crispa in skeletal muscle cells. Asian Biomed. 2008; 2:415-20.]Search in Google Scholar
[7. Klip A, Marette A. Acute and chronic signals controlling glucose transport in skeletal muscle. J Cell Biochem. 1992; 48:51-60.10.1002/jcb.240480109]Open DOISearch in Google Scholar
[8. Sakamoto K, Goodyear LJ. Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol. 2002; 93:369-83.10.1152/japplphysiol.00167.2002]Search in Google Scholar
[9. Fukumoto H, Kayano T, Buse JB, Edwards Y, Pilch PF, Bell GI, et al. Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem. 1989; 264:7776-9.10.1016/S0021-9258(18)83106-4]Search in Google Scholar
[10. Fingar DC, Birnbaum MJ. A role for Raf-1 in the divergent signaling pathways mediating insulinstimulated glucose transport. J Biol Chem. 1994; 269: 10127-32.10.1016/S0021-9258(17)36999-5]Search in Google Scholar
[11. Hausdorff SF, Frangioni JV, Birnbaum MJ. Role of p21ras in insulin-stimulated glucose transport in 3T3- L1 adipocytes. J Biol Chem. 1994; 269:21391-4.10.1016/S0021-9258(17)31813-6]Search in Google Scholar
[12. Hausdorff SF, Bennett AM, Neel BG, Birnbaum MJ. Different signaling roles of SHPTP2 in insulin-induced GLUT1 expression and GLUT4 translocation. J Biol Chem. 1995; 270:12965-8.10.1074/jbc.270.22.12965]Search in Google Scholar
[13. Yamamoto Y, Yoshimasa Y, Koh M, Suga J, Masuzaki H, Ogawa Y, et al. Constitutively active mitogenactivated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes. 2000; 49: 332-9.10.2337/diabetes.49.3.332]Open DOISearch in Google Scholar
[14. Abbud W, Habinowski S, Zhang JZ, Kendrew J, Elkairi FS, Kemp BE, et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys. 2000; 380:347-52.10.1006/abbi.2000.1935]Search in Google Scholar
[15. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, et al. Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMPactivated protein kinase (AMPK). J Cell Sci. 2002; 115: 2433-42.10.1242/jcs.115.11.2433]Search in Google Scholar
[16. Jing M, Ismail-Beigi F. Role of 5'-AMP-activated protein kinase in stimulation of glucose transport in response to inhibition of oxidative phosphorylation. Am J Physiol Cell Physiol. 2006; 290:C484-91.10.1152/ajpcell.00321.2005]Search in Google Scholar
[17. Wagner H, Bladt S. Plant drug analysis: A Thin Layer Chromatography Atlas. 2nd ed. New York: Berlin Springer-Verlag; 1996.10.1007/978-3-642-00574-9]Search in Google Scholar
[18. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990; 82:1107-12.10.1093/jnci/82.13.1107]Search in Google Scholar
[19. Kokta TA, Dodson MV, Gertler A, Hill RA. Intercellular signaling between adipose tissue and muscle tissue. Domest Anim Endocrinol. 2004; 27:303-31.10.1016/j.domaniend.2004.05.004]Open DOISearch in Google Scholar
[20. Ciaraldi TP, Knudsen KH, Hickman M, Olefsky JM. Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism. 1995; 44: 976-81.10.1016/0026-0495(95)90092-6]Open DOISearch in Google Scholar
[21. Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA. Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology. 1992; 130: 2535-44.10.1210/endo.130.5.15722811572281]Search in Google Scholar
[22. Hundal HS, RamLal T, Reyes R, Leiter LA, Klip A. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology. 1992; 131:1165-73.10.1210/endo.131.3.15054581505458]Search in Google Scholar
[23. Taha C, Mitsumoto Y, Liu Z, Skolnik EY, Klip A. The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters in L6 muscle cells is mediated by distinct pathways. Roles of p21ras and pp70 S6 kinase. J Biol Chem. 1995; 270: 24678-81.10.1074/jbc.270.42.246787559581]Search in Google Scholar
[24. Taha C, Liu Z, Jin J, Al-Hasani H, Sonenberg N, Klip A. Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation. J Biol Chem. 1999; 274:33085-91.10.1074/jbc.274.46.3308510551878]Search in Google Scholar
[25. Somwar R, Sumitani S, Taha C, Sweeney G, Klip A. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Am J Physiol. 1998; 275:E618-25.10.1152/ajpendo.1998.275.4.E6189755080]Search in Google Scholar
[26. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, et al. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. Mol Endocrinol. 2003; 17:487-97.10.1210/me.2002-013112554784]Open DOISearch in Google Scholar
[27. Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMPactivated protein kinase through distinct signaling pathways. J Biol Chem. 2002; 277:25226-32.10.1074/jbc.M20248920011994296]Search in Google Scholar
[28. Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol Metab. 2006; 17: 205-15.10.1016/j.tem.2006.05.00616766204]Open DOISearch in Google Scholar
[29. Ye JM, Dzamko N, Hoy AJ, Iglesias MA, Kemp B, Kraegen E. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats. Diabetes. 2006; 55:2797-804.10.2337/db05-131517003345]Open DOISearch in Google Scholar
[30. Kim SH, Shin EJ, Kim ED, Bayaraa T, Frost SC, Hyun CK. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biol Pharm Bull. 2007; 30: 2120-5.10.1248/bpb.30.212017978486]Open DOISearch in Google Scholar
[31. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMPactivated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006; 55:2256-64.10.2337/db06-000616873688]Open DOISearch in Google Scholar
[32. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007; 56: 405-12.10.1016/j.metabol.2006.10.02517292731]Open DOISearch in Google Scholar
[33. Bisset NG, Nwaiwu J. Quaternary alkaloids of Tinospora species. Planta Medica. 1983; 48:275-9.10.1055/s-2007-96993317404996]Open DOISearch in Google Scholar
[34. Srinivasan GV, Unnikrishnan KP, Rema Shree AB, Balachandran I. HPLC estimation of berberine in Tinospora cordifolia and Tinospora sinensis. Indian J Pharm Sci. 2008; 70:96-9. 10.4103/0250-474X.40341285207120390090]Search in Google Scholar